Last $0.60 USD
Change Today -0.0138 / -2.25%
Volume 119.4K
CYCC On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul McBarron

Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Executive Vice President of Finance & Administration, Secretary and Executive Director, Cyclacel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 5 different industries.

See Board Relationships
53$743,675
As of Fiscal Year 2013

Background*

Mr. Paul McBarron serves as the Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Executive Vice President of Finance & Administration and Secretary at Cyclacel Pharmaceuticals, Inc. (formerly, Xcyte Therapies Inc.). Mr. McBarron serves as an Australia Director of Freyssinet SAS. He has 16 years of experience as a Financial Executive with several pharmaceutical companies. He joined Cyclacel Group PLC in January 2002. He served as Chief Financial ...

Read Full Background

Corporate Headquarters*

200 Connell Drive
Berkeley Heights, New Jersey 07922

United States

Phone: 908-517-7330
Fax: 866-271-3466

Board Members Memberships*

Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Executive Vice President of Finance & Administration, Secretary and Executive Director
Former Chief Operating Officer, Principal Financial Officer, Executive Vice President of Finance, Secretary and Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary$334,398
Bonus$128,744
Total Annual Compensation$463,142

Stock Options*

All Other Compensation$22,372
Exercisable Options67,134
Exercisable Options Value$20,143
Unexercisable Options72,678
Total Value of Options$20,143
Total Number of Options139,812

Total Compensation*

Total Annual Cash Compensation$485,514
Total Short Term Compensation$463,142
Other Long Term Compensation$22,372
Total Calculated Compensation$743,675
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYCC:US $0.60 USD -0.0138

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYCLACEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.